NIAID Unveils Strategic Plan for Developing a Universal Influenza Vaccine

An effective universal flu vaccine must meet four criteria.


Developing a universal influenza vaccine — a vaccine that can provide durable protection for all age groups against multiple influenza strains, including those that might cause a pandemic — is a priority for the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.… Read full story